News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Ilana Schlam: Looking forward to important research being presented at SABCS24
Ilana Schlam/X
Nov 29, 2024, 18:11

Ilana Schlam: Looking forward to important research being presented at SABCS24

Ilana Schlam, Breast Medical Oncologist and Assistant Professor of Medicine at Tufts University Medical Center, shared a post on X:

“Looking forward to SABCS24 – there is a lot of important research being presented, some to highlight:

Biomarker analysis of KN522
EMBER-3
MARGOT
SONIA
EUROPA
SOLTI VALENTINE
GeparDouze.”

More posts featuring Ilana Schlam.

Ilana Schlam, MD, is a breast medical oncologist and Assistant Professor of Medicine at Tufts University Medical Center. Her research focuses on precision medicine, drug development, and addressing healthcare disparities in breast cancer treatment and outcomes.

cancer Ilana Schlam OncoDaily Oncology SABCS24
Special Coverage
Blog
Apr 18, 2025, 20:22
Applications are open for the ESMO Research Fellowship
Blog
Apr 18, 2025, 20:12
Caitríona Duggan: Delighted for the opportunity to share our work at MASCC
Blog
Apr 18, 2025, 20:03
Fumiko Ladd Chino: Honored to be invited to speak about financial toxicity
Blog
Apr 18, 2025, 20:02
Estelamari Rodriguez: ACS NLCRT Biomarker Workshop version of brainstorming with the stars
Blog
Apr 18, 2025, 19:54
Sami Mansfield: Fiber, the microbiome, and cancer care
Blog
Apr 18, 2025, 19:49
Eric K. Singhi Discusses Lung Cancer at ASCO 2025
Science
Apr 18, 2025, 19:44
Nirmala Bhoo Pathy: The need for race and ethnicity data in cancer control
Science
Apr 18, 2025, 19:28
Andreas Charalambous: Achieving digital transformation in cancer care across Europe
Blog
Apr 18, 2025, 19:26
SIOG - Older adults deserve better: Let’s close the gap in Cancer Care
Science
Apr 18, 2025, 19:10
Rafael Grochot: The safety and activity of FGFR inhibitors in early-phase clinical trials
Blog
Apr 18, 2025, 18:58
Mission Adaptation and Mission Cancer: Resilient Health Systems for Cancer - ECHoS
Blog
Apr 18, 2025, 18:55
Robert F. Kennedy Jr. visited U.S. FDA with Commissioner Martin Makary on Medical Innovation